JY
LKFT

Jeff Yass’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Jeff Yass’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55M Buy
151,886
+138,499
+1,035% +$3.93M ﹤0.01% 4802
2026
Q1 		$402K Buy
13,387
+6,419
+92% +$213K ﹤0.01% 10202
2025
Q4 		$228K Buy
+6,968
New +$225K ﹤0.01% 10581
2025
Q3 		– Sell
-15,183
Closed -$425K – 12947
2025
Q2 		$425K Sell
15,183
-7,729
-34% -$207K ﹤0.01% 9545
2025
Q1 		$576K Buy
+22,912
New +$579K ﹤0.01% 8595
2024
Q3 		– Sell
-30,842
Closed -$840K – 12356
2024
Q2 		$764K Buy
30,842
+22,558
+272% +$640K ﹤0.01% 7219
2024
Q1 		$267K Sell
8,284
-43,560
-84% -$1.62M ﹤0.01% 9971
2023
Q4 		$2.11M Buy
51,844
+45,134
+673% +$1.66M ﹤0.01% 5232
2023
Q3 		$232K Sell
6,710
-35,418
-84% -$1.38M ﹤0.01% 9898
2023
Q2 		$1.71M Buy
42,128
+1,654
+4% +$67.5K ﹤0.01% 5476
2023
Q1 		$1.56M Buy
40,474
+26,046
+181% +$1.07M ﹤0.01% 5706
2022
Q4 		$640K Sell
14,428
-12,811
-47% -$539K ﹤0.01% 7228
2022
Q3 		$1.16M Buy
+27,239
New +$1.4M ﹤0.01% 6251
2022
Q2 		– Sell
-13,013
Closed -$772K – 13266
2022
Q1 		$807K Sell
13,013
-36,393
-74% -$2.23M ﹤0.01% 7696
2021
Q4 		$2.72M Sell
49,406
-77,392
-61% -$4.04M ﹤0.01% 4824
2021
Q3 		$6.67M Buy
126,798
+80,145
+172% +$4.76M ﹤0.01% 3480
2021
Q2 		$3.21M Sell
46,653
-64,605
-58% -$4.93M ﹤0.01% 4869
2021
Q1 		$8.58M Buy
111,258
+86,737
+354% +$7.99M ﹤0.01% 3016
2020
Q4 		$2.43M Buy
+24,521
New +$3M ﹤0.01% 4698
2020
Q3 		– Sell
-25,114
Closed -$4.19M – 10743
2020
Q2 		$4.96M Buy
+25,114
New +$5.2M ﹤0.01% 3026
2020
Q1 		– Sell
-19,312
Closed -$4.16M – 10477
2019
Q4 		$3.99M Buy
+19,312
New +$3.57M ﹤0.01% 3292
2019
Q3 		– Sell
-2,824
Closed -$463K – 10401
2019
Q2 		$364K Buy
+2,824
New +$335K ﹤0.01% 7923
2018
Q4 		– Sell
-39,360
Closed -$3.99M – 9292
2018
Q3 		$4.42M Buy
39,360
+29,009
+280% +$3.06M ﹤0.01% 2827
2018
Q2 		$954K Buy
10,351
+4,424
+75% +$429K ﹤0.01% 5455
2018
Q1 		$591K Sell
5,927
-12,910
-69% -$1.39M ﹤0.01% 6287
2017
Q4 		$1.77M Sell
18,837
-847
-4% -$80.1K ﹤0.01% 4135
2017
Q3 		$2M Buy
19,684
+13,930
+242% +$1.22M ﹤0.01% 3914
2017
Q2 		$440K Buy
5,754
+1,213
+27% +$102K ﹤0.01% 6882
2017
Q1 		$391K Buy
+4,541
New +$327K ﹤0.01% 6935
2016
Q4 		– Sell
-3,434
Closed -$222K – 9772
2016
Q3 		$222K Buy
+3,434
New +$194K ﹤0.01% 7415

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jeff Yass's LKFT Position: Q2 2026 in Review

Jeff Yass increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 1,035% in Q2 2026, buying an estimated $3.93M and bringing the position to 151,886 shares worth $4.55M. The position accounts for ﹤0.01% of the portfolio, ranked #4802.

Jeff Yass first reported a position in LKFT in Q3 2016 and has held it in 30 quarters since. The position peaked at $8.58M in Q1 2021. 77 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Jeff Yass held 151,886 shares of Lakefront Biotherapeutics American Depositary Shares worth $4.55M as of Q2 2026.
  • Jeff Yass bought 138,499 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $3.93M.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #4802 holding.
  • Jeff Yass first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2016 and has held it in 30 quarters since.
  • Jeff Yass's Lakefront Biotherapeutics American Depositary Shares position peaked at $8.58M in Q1 2021.
  • 77 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.